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Abstract: The ability to adopt complex three-dimensional (3D) structures that can rapidly 
interconvert between multiple functional states (folding and dynamics) is vital for the 
proper functioning of RNAs. Consequently, RNA structure and dynamics necessarily 
determine their biological function. In the post-genomic era, it is clear that RNAs comprise 
a larger proportion (>50%) of the transcribed genome compared to proteins (≤ 2%). Yet 
the determination of the 3D structures of RNAs lags considerably behind those of proteins 
and to date there are even fewer investigations of dynamics in RNAs compared to proteins. 
Site specific incorporation of various structural and dynamic probes into nucleic acids 
would likely transform RNA structural biology. Therefore, various methods for 
introducing probes for structural, functional, and biotechnological applications are 





Incorporation of these probes using improved RNA ligation strategies promises to change 
the landscape of structural biology of supramacromolecules probed by biophysical tools 
such as nuclear magnetic resonance (NMR) spectroscopy, X-ray crystallography and 
Raman spectroscopy. Finally, some of the structural and dynamic problems that can be 
addressed using these technological advances are outlined. 
Keywords: dynamics, FRET, isotopic labeling, ligation, NMR, Raman, RNA dynamics 
and folding and structure, X-ray crystallography. 
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Increasingly RNA molecules have taken center stage as key informational, structural, catalytic, and 
gene-regulatory molecules [1]. Contrary to the traditional view of the flow of genetic information 
wherein RNA is considered a minor intermediary for information transfer, RNAs have now been 
shown to be involved in a wide range of biological processes. In the cytoplasm, ribosomal RNAs 
catalyze and regulate protein synthesis [2-3], whereas in the nucleus small nuclear RNAs bound to 
proteins catalyze and regulate pre-RNA splicing [4-5]. In the nucleolus, small nucleolar RNAs 
(snoRNAs) form complexes with proteins to remodel the pre-ribosomal RNAs via methylation and 
pseudouridylation [6]. Finally, bacterial riboswitches influence transcription or translation by directly 
sensing metabolites or other environmental cues [7-8]. Unexpectedly, analysis of the human genome 
data reveals that only ~ 1.5 % of the genome encodes proteins; about 60-70% of the genome represents 
non-protein coding transcribed RNA [9, 10]. Nevertheless, of the structures deposited in the Protein 
Data Bank, proteins constitute 95%, whereas RNAs account for less than 2% (Figure 1).  
Figure 1. Inverse correlation between the genomic outputs of RNAs and proteins and the 
number of solved 3D structures deposited in the protein data bank.  
 
The calculation of 3D structures of RNA molecules by NMR and X-ray crystallography have, 
therefore, lagged substantially behind those of proteins. For NMR, this lag is partly because of 
extensive signal overlap and the rapid signal decay that occurs with increasing molecular weight. For 
X-ray crystallography, RNA structures have been difficult to solve partly because of RNA flexibility 
and the difficulty of finding suitable constructs that are able to diffract to high-resolution, as well as 
finding suitable heavy atom derivatives for phase determination. Recently, a number of emerging 
technologies make the prospects of tackling large supramacromolecular RNA complexes both 
probable and doable by various biophysical methods such as NMR, fluorescent resonance energy 
transfer (FRET), Raman, and X-ray crystallography. Several excellent reviews describe the technical 
details of NMR RNA structure calculation [11], advances in RNA NMR methodology [12-15], and 
RNA X-ray crystallography [16-19]. Here, we outline the various methods for preparing milligram 
quantities of natively folded RNA without denaturing and refolding, new methods for incorporating Int. J. Mol. Sci. 2008, 9                           
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specific labels into RNA, efficient techniques for ligating RNAs together, and prospects for tackling 
large macromolecules by NMR spectroscopy and X-ray crystallography. 
2. Synthesis and purification of milligram quantities of natively folded RNA for biophysical 
studies 
NMR spectroscopic and X-ray crystallographic analyses require large milligram quantities of pure 
and functionally active materials. Chemical or biochemical methods allow synthesis of large quantities 
of RNA. While the chemical synthetic method affords site-specific incorporation of both standard and 
non-standard nucleobases into RNA, the labeled precursors are usually expensive and difficult to 
synthesize. Although chemical synthesis of RNA has improved considerably over the past decade, this 
method is highly inefficient beyond 50 nucleotides (nt) [20]. In this section both traditional methods 
and three new and improved methods for preparing natively folded RNAs are reviewed. 
2.1 T7 RNA polymerase based transcription of RNA 
The in vitro transcription with various DNA dependent polymerases such as SP6, T3, or T7 is a 
widely used enzymatic method [21-24] that overcomes some of the limitations of the chemical method. 
In vitro transcription by T7 polymerase has become the standard procedure for making RNA for many 
biophysical studies, however. Yet the T7 polymerase-based approach has at least three serious 
limitations. First, the widely used T7 consensus promoter (class III φ6.5 promoter) requires a 
guanosine as the first nucleotide for efficient initiation, as well as two or more consecutive guanosines 
at the first two to three nucleotide positions [22, 24]. This purine rich requirement at the 5'-end 
significantly restricts the types of RNA sequences that can be synthesized efficiently. Second, repeated 
abortive transcription initiations result in a high degree of 5'-end heterogeneity [25, 26]. Third, T7 
RNA polymerase adds one or more nontemplated nucleotides at the 3'-end of the nascent RNA 
transcript to produce fragments that are longer than expected. These N+1 and N+2 products can be 
produced in equimolar or higher amounts than the desired product [22, 27]. Previous reviews describe 
the advantages and limitations of using DNA templates of various lengths for transcription, common 
RNA refolding schemes, and the resolution of various purification methods at the nucleotide level [22, 
28-29]. Here those limitations that have been addressed recently are detailed.  
Several approaches have been proposed to circumvent these heterogeneity problems. The 3'-end 
heterogeneity problem can largely be overcome using cis- or trans-acting ribozymes to cleave at 
specific positions to leave homogenous length RNA [30, 31]. Another method makes use of non-polar 
nucleoside analogues (4-methylindole β-deoxy nucleoside) [32] or DNA templates modified in the two 
terminal nucleotide positions with 2'-methyoxyribose sugars to substantially reduce the 3'-end 
heterogeneity [33]. Similarly, the T7 class II φ2.5 promoters that initiate transcription with adenosine 
triphosphates (ATP) and ATP analogues have been shown to possess superior 5'-homogeneity 
compared to the GTP-initiating T7 class III φ6.5 promoters [34]. The use of cytidine at the beginning 
of the template strand together with 2'-methoxyribose is adequate to improve yield and reduce 
heterogeneities [35]. In our experience, transcription optimization using a sparse-matrix approach is 
necessary for optimal yield. For example, the concentrations of Mg
2+, NTP, and the T7 RNA Int. J. Mol. Sci. 2008, 9                           
           
 
1217
polymerase can be varied systematically to achieve an optimum yield of the full length product that 
can reach up to 5 A260 units/ml of transcription [29, 35]. 
An implicit assumption in all discussions about making RNAs is that T7 polymerase-based 
transcribed RNAs are correctly and homogenously folded. To evaluate this possibility before investing 
substantial effort and time into a non-denaturing purification scheme, it is important to show that the 
RNA adopts the structure of interest at the concentrations needed for the biophysical studies. Access to 
appropriate biochemical and functional assays are useful in this regard. 
A completely different in vivo method, that may alleviate some of these concerns, was recently 
illustrated by Ponchon and Dardel [36]. The authors described a generic approach to express and 
purify structured RNAs in Escherichia coli (E.coli) using tRNA-RNA fusions, similar to glutathione 
S-transferase fusions used for protein expression. This tRNA fusion serves to protect the desired RNA 
from cellular RNAse degradation of [36]. It remains to be seen how general this approach will be for 
synthesizing large RNAs with complex domains or RNAs with significant single-stranded regions. 
2.2 Native purification of RNA for biophysical studies 
After in vitro or vivo synthesis, the target RNA is purified away from unwanted side-products and 
unused reactants using traditional denaturing or non-denaturing methods. The traditional purification 
methods include anion-exchange high-performance liquid chromatography (HPLC) [37-39], ion-pair-
reversed phase HPLC [40-42], and denaturing polyacrylamide gel electrophoresis (PAGE) [28, 43-44]. 
For short RNAs (<20 nt) the HPLC methods can be used to produce homogenous-length RNAs 
rapidly, and for medium-sized RNAs (<50 nt) the preparative denaturing PAGE method is a robust and 
well-established method of choice. Nonetheless, both HPLC and PAGE methods denature the RNA; 
then the RNA is refolded following purification. Furthermore, the step preceding the gel loading 
requires phenol-chloroform extraction, which may result in sample loss and RNA aggregation. Finally, 
a 20 ml transcription reaction requires at least four conventional 40 x 60 x 0.3 cm
3 PAGE gel runs that 
are tedious and time-consuming. Three promising approaches to avoid the denaturing steps of 
preparation and to speed up the purification process are outlined below (Figures 2 and 3). 
 
2.2.1 DNA affinity column chromatography for native purification of RNA 
Cheong and coworkers [45] used trans-acting DNA enzymes (DNAzymes) and DNA affinity 
column chromatography to purify milligram quantities of RNA in 3 days (Figure 2). The affinity 
column was synthesized chemically using 1 gram of Oligo Affinity support from Glen Research. A tag 
sequence appended to the 3'-end of the RNA binds a complementary DNA sequence on the column 
allowing the abortive transcripts, DNA template, T7 polymerase, and unused NTPs to be washed off 
the column. The bound RNA is eluted under low salt conditions and then digested with the DNAzyme 
to produce homogenous 3'-ends. The affinity column further separates this mixture by retaining the 3'-
affinity tag on the column, but the target RNA or the DNAzyme flows through. Finally, the DNAzyme 
is digested with DNAse I followed by size exclusion chromatography. The authors do not indicate the 
attainable yield. However, it is likely the ratio of the final product to the initial transcript is 
substantially less than 50%. The approach solves the 3'-heterogeneity problem, and it obviates the need Int. J. Mol. Sci. 2008, 9                           
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for a denaturing preparation. The method, however, does not solve the 5'-heterogeneity problem. But 
this problem can be easily rectified using other DNAzymes or a hammerhead ribozyme construct at the 
5'-end. Such an improved affinity capture method could make it more high-throughput and broadly 
adopted by the biophysical community in the future.  
Figure 2. Schematic of native purification of RNA using self-cleaving DNAzyme affinity 
chromatography. The DNAzyme has a core structure of 15 nt and two flanking arms of 7-
13 nt which can hybridize to the target RNA, and 15 of the 20 nt of the DNA affinity tag is 
complementary to the target RNA. 
 
2.2.2 Protein-RNA affinity column chromatography for native purification of RNA 
Concurrently, the groups of Batey and Kieft also proposed a general method for purifying RNA 
under native conditions within 24 hours. They took advantage of an RNA-protein interaction to 
immobilize the transcribed RNA onto an affinity column and an imidazole activated hepatitis delta 
virus (HDV) to cleave the desired product off the column [46]. Their two domain affinity tag 
contained a cytidine-to-uridine (C75U) variant of the HDV ribozyme and a stem loop RNA motif from 
a thermostable signal recognition particle (SRP) that binds tightly and specifically to the SRP protein, 
the Ffh-M domain protein. The transcribed RNA is run over an affiGel affinity column to which the 
Fth protein has been immobilized. Abortive transcripts, DNA template, T7 polymerase and other 
unwanted products come off the column while the full-length RNA remains on the column. Addition 
of high concentration imidazole, ~200 mM, cleaves the target RNA and enables a clean elution of the Int. J. Mol. Sci. 2008, 9                           
           
 
1219
RNA. Unfortunately, this earlier version had many technical problems, which have been addressed 
subsequently [47]. First, the Ffh-M domain protein precipitates in low salt concentration during cation 
exchange chromatography and the column coupling steps. Second, the columns become ineffective 
after repeated use. Third, the use of very high imidazole concentrations for the cleavage step on the 
column significantly degrades the RNA, and for certain RNA sequences cleavage remains incomplete 
even after prolonged incubation [47].  
To improve on the older design, Batey and Kieft now replaced the problematic Fth protein with a 
his-tagged form of the maltose binding protein (MBP)-MS2 coat fusion protein that can bind to the 
widely used Ni
2+ [48] affinity columns (Figure 3). They substituted the mutant HDV ribozyme with 
the glmS ribozyme that can be activated by glucosamine-6-phosphate (GlcN6P) at low concentration 
of ~1 mM [49]. In place of the Fth-M RNA binding site, they inserted two copies of the MS2 coat 
protein binding RNA stem-loops upstream of the glmS ribozyme.  
Figure 3. Schematic of native purification of RNA using self-cleaving glmS Ribozyme 
(~140 nt) and Ni
2+ affinity chromatography. The MS2 coat protein binding RNA stem-
loops is 43 nt. 
 
With this new scheme, small and large scale purifications can be conveniently carried out. For 
small-scale RNA synthesis, the entire in vitro transcription reaction is pre-incubated with the MBP-
MS2 protein and the resulting complex is applied to a Qiagen Ni
2+ spin column. For large scale 
preparation, the complex is applied to a Qiagen Ni
2+-agarose resin packed into a disposal column. Int. J. Mol. Sci. 2008, 9                           
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After washing off incomplete transcripts and unused NTPs, the product RNA is eluted with 1mM 
GlcN6P (Figure 3). To prevent substantial amount of background cleavage in low concentrations of 
Tris (~ 10mM), the authors recommend the use of K
+-HEPES.  
This method has a few disadvantages. First, it can be further improved by incorporating schemes to 
suppress 5'-end heterogeneity as discussed above. From hydroxyl radical footprinting experiments, 
Hampel and Tinsley showed that the first four unpaired nucleotides upstream from the cleavage site of 
the glmS ribozyme are protected [50]. Thus, a minimum structural requirement for cleavage might be 
four bases from the 5' cut site. Finally, the cleavage by glmS ribozyme leaves an adenine at the 3'-end 
of the RNA product. So far as it does not affect function, this extra adenine is small price to pay for 
obtaining natively-folded RNA samples. 
2.2.3 Size exclusion chromatography for native purification of RNA 
Alternatively, Puglisi and colleagues have employed size-exclusion chromatography to purify large 
RNAs in a day [51, 52]. A recent publication from this group provides details of the practical 
applications of this method [53]. In their method, after quenching with EDTA, the reaction mixture is 
subjected to phenol-chloroform extraction to remove the restriction enzyme carried over from the 
DNA template digestion and T7 RNA polymerase. A desalting column then removes any remaining 
phenol and NTPs. The resulting aqueous phase is applied to either a Superdex 200 size-exclusion 
column for RNAs between 120 and 400 nt or to Superdex 75 for RNAs between 10 and 150 nt.  
A drawback of this method is the phenol-chloroform extraction step, which can result in RNA 
aggregation, sample loss and inability to resolve RNAs with heterogenous ends. The method, 
nevertheless, should become very rapidly adopted because of the ease of operation, the ability to 
separate monomeric and higher-order conformations, and the facile removable of water soluble 
acrylamide contaminants that plague polyacrylamide gel electrophoresis methods.  
In sum, the methods of affinity and size-exclusion chromatography, unlike PAGE and HPLC that 
denature the RNAs, should prove very useful for preparing natively folded RNAs for functional 
studies and biophysical characterization. 
3. Isotopic labeling of RNA for biophysical studies 
Access to 
15N and/or 
13C labeled proteins, which were enriched from <1% to close to 100% 
15N/
13C, 
led to the development of multidimensional heteronuclear NMR experiments, and the transformation 
of solution NMR structure determination of proteins. Similar advances in methods for synthesizing 
isotopically labeled RNA [43-44, 54-55], which immediately followed the protein advance [56], 
inspired development of new heteronuclear NMR experiments [13-15, 57-59].  
Even so, it soon became clear that 
13C and/or 
15N labeling was very useful for medium sized RNAs 
(≤ 30 nt) only. As the size of the RNA increased, two challenges facing RNA structural biology 
become even more acute: extensive spectral crowding and increased resonance linewidths. The 
spectral overlap problem is acute for RNA because the non-exchangeable ribose protons (H2'-H5', 
H5'') resonate in a very narrow chemical shift range of 1 ppm. The number of protons within this 
spectral window scales linearly with the number of nucleotides in an RNA molecule without a change 
in spectral width. As a result, the spectral overlap in RNA molecules > 40 nt is so severe that Int. J. Mol. Sci. 2008, 9                           
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assignment of the individual resonance peak positions is extremely challenging. Additionally, line 
broadening results from faster relaxation of the magnetization, and this effect increases proportionally 
with molecular weight (Figure 4). Because of all these problems, alternate labeling strategies have 




2H labeling, and 
19F labeling are outlined.  
Figure 4. Small molecules in solution tumble rapidly and the corresponding NMR signal 
decays slowly and has narrow linewidth, whereas large molecules tumble slowly in 
solution and the resulting NMR signal decays rapidly and has broad lines; these broad lines 




13C isotopic labeling of RNA for biophysical studies 
To overcome the overlap and relaxation problems, RNAs can be labeled uniformly, randomly, or 
site-specifically with stable isotopes (Figure 5). The preferred labeling pattern is accomplished by 
growing either E.coli or Methylobacterium on defined chemical media and harvesting the total cellular 
RNA. Enzymatic digestion of the cellular RNA to nucleotide monophosphates (NMPs) and 
rephosphorylation of the NMPs yields the nucleotide triphosphates (NTPs) needed for in vitro RNA 
transcription.  
In the past, 
13C or 
13C/
15N labeled nucleotides were produced by growing the organism 
Methylophilus methylotrophus (M. methylotrophus) [44] or Methylobacterium extorquens [55] on 
13C-
methanol for three reasons. First, methanol was a very economical source of 
13C label at the time this 
method was developed; that is, the price difference between 
13C labeled methanol and glucose was 
approximately 600% [44]. These prices are now comparable. Second, a maximum yield of RNA was 
achievable for every gram input of labeled methanol. M. methylotrophus grows rapidly on methanol 
with a doubling time of 1.9 hours, and the percentage of dry cell weight that is RNA increases with a 
decrease in doubling time. Third, the use of methylotrophs enables partial and random incorporation of 
both 
13C and 
2H [55, 60].  
 Int. J. Mol. Sci. 2008, 9                           
           
 
1222
Figure 5. Strategies to prepare isotopically enriched RNA using labeled carbon and 
nitrogen sources. 
 
Compared to E.coli, the use of methylophiles has four disadvantages. First, isotopic scrambling 
during biosynthesis prevents incorporation of site-specific isotopic labels using methanol. Second, 
methylophiles have significantly lower ribonucleotide content per gram of cells. Specifically, the yield 
of NMPs from M. methylotrophus is 42% of that for E.coli [44]. Third, the growth of M. 
methylotrophus is not as easily controlled as that of E.coli. And fourth, methylophiles are less 
accessible to many investigators familiar with use of E.coli for making proteins [44]. For all these 
reasons, E.coli is likely going to be favored over methylobacteria for labeling RNA. 
3.2 Alternate site-specific 
13C isotopic labeling of RNA with different E.coli strains 
For RNAs 30 nt or smaller the resolution afforded by uniform labeling can be spectacular, but for 
larger RNAs alternative labeling strategies are needed to overcome both the crowding and increased 
linewidth problem. To address some of these limitations, various groups have developed single and 
multiple residue type labeling with some limited success [57, 61-62]. 
A promising option to alleviate the overlap problem is to grow various strains of E.coli on different 
combinations of carbon and nitrogen sources to achieve alternate site-specific labeling. Wild-type 
E.coli can be grown on 
13C-sodium acetate as the sole carbon source, but the distribution of 
13C atoms 
within the nucleotides that results is not uniform [63]. In other words, depending on which carbon site 
is labeled in the acetate carbon source, different parts of the ribonucleotide are labeled. For example, 
growing wild-type E.coli on 
13CH3COONa as the only carbon source leads to >90% labeling efficiency Int. J. Mol. Sci. 2008, 9                           
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of not only the carbon positions of C5 and C6 within pyrimidine rings but also the carbon positions of 
C2, C6 and C8 within purine rings. Moreover, all the carbon positions, except the C3' position, within 
the ribose ring are labeled at 80-90% efficiency. Of great interest, the resulting NTPs are highly 
13C-
enriched at all the positions useful for proton-detected NMR experiments. This labeling pattern, 
however, does not alleviate the problem of strong 
13C-
13C J-coupling for either the C5 and C6 
positions within pyrimidine ring or for all the carbon positions within the ribose ring. As a second 
example, growing wild-type E.coli on CH3
13COONa as the only carbon source leads to >90% labeling 
efficiency of the carbon positions of C2 and C4 within pyrimidine rings and C4 and C6 within purine 
rings. In this case, the resulting NTPs are highly 
13C-enriched at positions not useful for proton-
detected NMR, but may be beneficial for other biophysical applications such as Raman spectroscopy 
or Mass spectrometry.  
The growth of E.coli on 
13C-formate and unlabeled glucose, on the other hand, leads to site-specific 
incorporation of the 
13C label at the C8 position of purines with >85% efficiency [59]. Selective 
labeling of the C8 carbon in purines removes the 
13C-
13C J-couplings to C4 and C5 carbons. Besides, 
this label eliminates the overlap of the C8 and C4/C5/C6 carbon atoms that resonate in similar spectral 
regions. Since both coupling and overlap problems interfere with accurately analyzing T2-CPMG 
(Carl-Purcell-Meiboom-Gill) data used for relaxation measurements, this C8 specific labeling strategy 
is advantageous for the analysis of 
13C relaxation data. 
Hoogstraten and his group adopted an alternate-site isotopic labeling scheme for incorporating 
13C 
label into specific ribose carbon positions using mutant E.coli strains [64]. By growing an E.coli strain 
deficient in the trichloroacetic acid cycle (DL323, available from the Yale Coli Genetic Stock Center, 
#7538) on 2-
13C glycerol, a mixture of partially labeled 1', 4'-
13C (55%) and 2', 4'-
13C (30%) ribose 
isotopomers are obtained. Likewise, the DL323 E.coli strain grown on 1, 3-
13C-glycerol yields ~90% 
13C label at only the C5 position of CMP, and when grown on 2-
13C-glycerol gives ~90% 
13C label at 
only the C6 position of CMP. Another E.coli strain deficient in the glucose-6-phosphate 
dehydrogenase pathway, strain K10-1516 (available from the Yale Coli Genetic Stock Center, #4858), 
grown on 2-
13C-glycerol gives superior labeling mostly at the C2' (~98%) and C4' (>95%) ribose 
positions. As an added benefit, this latter labeling scheme gives 50% labeling efficiency for both C5 
and C6 carbon sites in the purine ring. Overall, the K10-1516 strain is the most attractive for 
selectively labeling at C2' and C4' and C5/C6 positions at >80% efficiency. These labels largely 
remove the 
13C-
13C interference effects. Hoogstraten and Johnson recently described how these labels 
effectively remove these couplings [65]. As a result, they provide an ideal two-spin system for NMR 
relaxation studies. Finally, their use in labeled RNA should enable analysis of RNA spectral regions 
that are notoriously overcrowded without resorting to complex NMR experiments [35, 66].  
3.3 Deuterium (
2H) isotopic labeling of RNA for biophysical studies 
Of the many isotopic labeling approaches proposed to deal with both the overlap and the rapid 
relaxation problem, use of deuterium labeling remains the most attractive for improving spectral 
resolution and combating the relaxation problem [67-73]. Deuterium labeling of RNA functional 
groups increases the level of deuterium from the natural abundance value of 0.015% to >90%. 
Deuterium has a gyromagnetic ratio that is ~6.5 times smaller than that of hydrogen. Therefore, Int. J. Mol. Sci. 2008, 9                           
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relative to protons, the relaxation rates of the deuterium spin attached to a heteroatom such as 
13C or 
15N is scaled down by 2% [(γD/γH)
2 ~ 0.02]. In addition, the energy of transition for deuterium is very 
different from that of hydrogen such that the deuterium resonances are absent in a proton NMR 
spectral region. Of the two types of deuterium labeling, random fractional deuteration, wherein 
organisms are grown on partially deuterated carbon sources in a partial D2O solvent mixture, is not as 
effective for RNA NMR as it is for protein NMR. In contrast, specific deuteration, where 
2H is placed 
in a specific location of a macromolecule, results in homogenous labeled molecules without uniform 
reduction in signal intensity (Figure 6). This makes the specific deuteration approach very attractive. 
Figure 6. By eliminating competing relaxation pathways among dipolar coupled protons, 
deuteration leads to reduced linewidths, increased signal-to-noise and reduced chemical 





19F isotopic labeling of RNA for biophysical studies 
By using various combinations of uniformly or specifically labeled glucose, the Williamson group 
showed that the ribose ring can be differentially labeled [70-71, 74-77]. Several applications have been 
reported [70-71, 75-77]. Because of the generality of this approach, we next outline this synthetic 
strategy in some detail. 
In the enzymatic synthetic strategy adopted by the Williamson group (Figure 7), glucose is 
converted into the activated 5-phospho-D-ribosyl-α-1-pyrophosphate (PRPP) using the enzymes of the 
pentose phosphate pathway. This activated PRPP is converted into the four nucleoside triphosphates 
(ATP, GTP, UTP; CTP is prepared from UTP in a separate reaction) using phosphoribosyltransferases. 
This efficient enzymatic synthesis begins with the C6-phosphorylation of glucose by hexokinase to 
give glucose-6-phosphate (G6P). This C1 aldose (G6P) is oxidized by glucose-6-phosphate 
dehydrogenase to 6-phosphogluconate (6PG), and in turn 6-phosphogluconate dehydrogenase 
decarboxylates this β-keto carboxylic acid (6PG) to ribulose-5-phosphate (Ru5P). Ru5P is then 
isomerized to ribose-5-phosphate (R5P) by ribose-5-phosphate isomerase. Alternatively, ribokinase Int. J. Mol. Sci. 2008, 9                           
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can directly phosphorylate the C1 position of ribose to generate R5P [76]. R5P, from either glucose or 
ribose, is then converted to PRPP by the phosphorylation of R5P’s C1 position by PRPP synthetase.  
Figure 7. Schematic of the enzymatic reaction to convert (un)labeled ribose or glucose to 
the four NTPs needed for RNA synthesis. Most of these enzymes are available from 
Sigma-Aldrich unless indicated otherwise. The enzymes (only those not commercially 
available are indicated as NA) involved are: (a) hexokinase (E.C.2.7.1.1), (b) glucose-6-
phosphate isomerase (E.C.5.3.1.9), (c) glucose-6-phosphate dehydrogenase (E.C.1.1.1.49), 
(d) 6-phosphogluconate dehydrogenase (E.C.1.1.1.44), (e) ribose-5-phosphate isomerase 
(E.C.5.3.1.6), (f) ribokinase (E.C.2.7.1.15; NA), (g) PRPP synthetase (E.C.2.7.6.1; NA), (h) 
adenine phosphoribosyltransferase (E.C.2.4.2.7; NA), (i) xanthine-guanine 
phosphoribosyltransferase (EC.2.4.2.22; NA), (j) uracil phosphoribosyltransferase 
(E.C.2.4.2.9; NA), (k) myokinase or adenylate kinase (E.C.2.7.4.3), (l) guanylate kinase 
(E.C.2.7.4.8), (m), nucleoside monophosphate kinase (E.C.2.7.4.4; Roche), (n) pyruvate 
kinase (E.C.2.7.1.40), (o) enolase (E.C.4.2.1.11), (p) 3-phosphoglycerate mutase 
(E.C.5.4.2.1; USB), and (q) CTP synthetase (E.C.6.3.4.2; NA). Note that for the last step of 
making CTP from UTP, L-glutamine or NH3 can be use for the amination reaction. In 
addition, the reductive amination of α-ketoglutarate is catalyzed by glutamic 
dehydrogenase (E.C.1.4.1.3). 
 
At this point in the synthesis a variety of labeled or unlabeled free bases can be directly coupled to 
PRPP. These condensation reactions are catalyzed by phosphoribosyltransferases specific for any of 
the bases, or modified forms of the bases (adenine, guanine, uracil, and their derivatives), to form 
nucleotide monophosphates (AMP, GMP, and UMP). The NMPs are subsequently converted to the 
nucleotide triphosphates by the sequential action of adenylate kinase or myokinase, guanylate kinase, 
nucleoside monophosphate kinase, and pyruvate kinase. The five phosphates and two oxidizing 
equivalents required for this synthesis are provided by ATP and NADP
+. The ATP consumed during Int. J. Mol. Sci. 2008, 9                           
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the reaction is regenerated in situ from phosphoenolpyruvate (PEP) by the action of enolase and 
pyruvate kinase. 3-phosphoglycerate mutase converts the relatively inexpensive D-(-)-3-
phosphoglyceric acid (3PGA) to D-(+)-2-phosphoglyceric acid (2PGA), enolase forms PEP from 
2PGA, and then pyruvate kinase catalyses the conversion of ADP to ATP [78-79]. The NADP
+ 
required for oxidizing G6P and 6PG is regenerated by reductive amination of α-ketoglutarate with 
NADPH and ammonia catalyzed by glutamic dehydrogenase [80]. 
A key advantage of this labeling scheme is the ability to mix and match various combinations of 
labeled glucose or ribose with labeled bases. Again, this enzymatic strategy allows for the facile 
exchange of the C1' and C2' ribose positions with either 
1H or 
2H. Glucose-6-phosphate isomerase 
catalyzes the exchange of the solvent hydrogen or deuterium atoms with the atom attached to the C2 
position of G6P. Specifically, if 
2H is desired at the H2' position then the reaction is better carried out 
in D2O and if 
1H is desired then the reaction must be conducted in H2O. Thus, omission of glucose-6-
phosphate isomerase leads to selective protonation or deuteration of the C2' ribose position. As an 
unavoidable, but desirable, side effect of the pentose phosphate pathway, the proton destined to 
become the H2' proton comes from the solvent milieu. R5P isomerase is able to remove a solvent 
molecule originally placed at the C1 position of Ru5P to its C2 position to form R5P. The combined 
action of R5P isomerase and G6P isomerase enables a combinatorial labeling of the C1’ and C2’ 
positions with either 
1H or 
2H. 
Using this general strategy, the Williamson group has produced several isotopic labeling patterns 
[70-71, 75-77, 81-82]. Starting from fully deuterated [1, 2, 3, 4, 5, 6, 6-
2H7]-d-glucose and conducting 
the reaction in D2O without G6P isomerase, 84% of the starting glucose is converted to the four NTPs 
with the ribose fully deuterated, a label called d6-NTP. By repeating this reaction in water and in the 
presence of G6P isomerase, the H1' and H2' ribose positions are selectively protonated in a 
background of deuterated ribose. This label is called d4-NTP. By carrying out the reaction in H2O with 
G6P isomerase using completely deuterated and uniformly 
13C labeled [1, 2, 3, 4, 5, 6, 6-
2H7-1, 2, 3, 4, 
5, 6-
13C]-d-glucose, d4-
13C-ribose NTPs are easily prepared [70-71]. By simply omitting G6P 
isomerase and carrying out the reaction in H2O using completely deuterated and uniformly 
13C labeled 
glucose shown above, d5-
13C-ribose NTPs are easily prepared.  
All five isotopic labeled patterns are valuable for NMR spectroscopic analysis of RNA structure 
and dynamics. The d4-
13C-ribose NTPs are valuable for preparing RNA uniformly 
13C-labeled in the 
ribose ring with H3', H4', H5'/H5'' protons specifically replaced with deuterons [71]. This labeling 
pattern simplifies the carbon heteronuclear single quantum correlation (HSQC) spectrum by removing 
the H3'-C3' resonances that normally obscure the H2'-C2' resonances. Furthermore, this d4 labeling 
pattern retains most of the useful structural information: the H1'-H2' scalar coupling that reports on 
ribose pucker; base to H1' NOE that provides the glycosidic torsion; and exchangeable protons that 
provide base pairing information [71]. These set of nucleotides (d4, d4-
13C, d6, and combinations of d4 
and d6) are important for NMR because their incorporation into an RNA molecule is valuable for 
recording NMR experiments that are easy to interpret and analyze. For example, the nuclear 
Overhauser spectroscopy (NOESY) experiment of such a sample has very interpretable base to ribose 
proton region that is difficult to assign otherwise [70, 75]. RNAs made with the d5-
13C-ribose pattern 
have only the 2'-position protonated, and all the other ribose protons are specifically replaced with 
deuterons as described in detail next. Int. J. Mol. Sci. 2008, 9                           
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The research group of Kay, in collaboration with the Williamson group, showed that d5-
13C-NTPs 
can be useful for relaxation analysis [77]. Here, the ribose sugar is not only protonated specifically at 
the 2'-position and all other positions remain deuterated, but also all the sugar carbons are 
13C-labeled 
and the pyrimidine bases were 
2H-labeld at the C5 position. This labeling strategy represents a 
significant improvement over partial (50%) deuteration within a fully ~100% 
13C-enriched background 
because the latter selects ~25% signals with concomitant compromise in sensitivity. With close to 
100% 
2H label at C1', C3', C4', and C5' carbon sites, the authors probed the backbone dynamics of 
most of the deuterated sites in HIV-2 TAR RNA [77].  
As another excellent example of the versatility of this enzymatic approach, Fluorine-19 (
19F) 
nucleus can be incorporated into RNA bases [81-82]. This is apt because 
19F can provide a wealth of 
geometrical and dynamical information about RNA molecules. 
19F is not endogenously expressed in 
biological molecules making it a valuable probe, it has 100% natural abundance and a gyromagnetic 
ratio comparable to that of a proton (γF~0.94γH) which means it possesses an intrinsic sensitivity 
almost as high as that of a proton. Importantly, 
19F also offers chemical shift dispersion (~900 ppm) 
~50 times larger than that obtainable from protons. Recently, the research groups of Henning and 
Williamson proposed a facile T7 RNA polymerase based incorporation of 5-Fluoro Cytidine, 5-Fluoro 
Uracil and 2-Fluoro Adenine into a 30 nt HIV-2 TAR RNA construct [81-82]. 
On the whole, the Williamson approach is extremely flexible in decoupling ribose from base 
labeling. The commercial availability of all these labeling patterns (from Cambridge Isotope Labs and 
Cassia LLC) and further development of other labels will greatly facilitate structure determination of 
large RNAs especially using ligation strategies (See below).  
Two limitations of this enzymatic approach must be overcome to make this method widely adopted 
by the biophysics community. First, the price for bases with various labels is high. Uracil uniformly 
labeled with 
13C and 
15N (U-13C4, 99%; U-15N2, 98%) currently lists at $750 for 0.1 g from 
Cambridge Isotope Laboratories. Incorporating the commercially available bases into the enzymatic 
labeling scheme would, therefore, be a costly method. Second, 7 out of the 18 enzymes required for 
synthesis are not commercially available and must be produced from over-expressing E.coli strains. Of 
these seven, only ribokinase and APRT have robust activities of 350-700 U (U, the activity of the 
purified protein from a 1 L culture, is defined as the amount of the enzyme that catalyses the reaction 
of 1 μmol of substrate per minute). The other five are only moderately over-expressed with activities 
of 28-40 U, making the enzyme preparation labor intensive [70, 74, 76]. By finding cheaper avenues to 
make labeled bases and constructs that highly over-express several of the commercially unavailable 
enzymes, the cost and labor required to synthesize these isotopically labeled NTPs could be 
significantly reduced. 
3.5 Phasing strategies in RNA crystallography 
X-ray crystallography is the other powerful approach for 3D structure determination of 
macromolecules. A substantial barrier for RNA structure determination by X-ray crystallography is 
heavy atom derivatization for phase determination [17, 83]. The phase problem arises because an X-
ray diffraction experiment yields intensities without the phase information needed for reconstructing 
the original electron density.  Int. J. Mol. Sci. 2008, 9                           
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In the past RNA crystallization tags have been used to address this problem. One example is the 
“soak and pray” method, wherein heavy atoms are soaked into the crystal to help with anomalous 
scattering [84-86]. Others involve RNA covalent modification with halogens or other heavy atoms [87-
89], and introduction of protein binding sites into the RNA constructs [90-91]. Here two recent 
methods that appear promising to resolve the RNA crystallography phasing problem are presented. 
3.5.1 Selenium (Se) labeling of RNA for biophysical studies 
One method, multiple anomalous dispersion (MAD), aims to solve the phase problem by using 
intrinsic or exogenous anomalous scatterers. Incorporation of Selenium, an attractive element for 
derivatization of biomolecules, into proteins led to an explosive growth of new protein crystal 
structures. In contrast to proteins, derivatizing nucleic acids for X-ray crystallography has lagged 
behind. Recently the groups of Egli, Huang, and Micura have developed a selenium derivatization 
strategy for nucleic acids (Huang and Sheng provide greater detail in this series, [92]). Two positions 
within the nucleic acids have been derivatized, either by replacement of the 2'-OH with a 2'-
methylseleno group (Figure 8) or replacement of the non-bridging phosphorus atom in the 
phosphodiester backbone. For instance, Huang and colleagues recently derivatized the hammerhead 
ribozyme with 5'-(α-P-seleno) NTPs using T7 RNA polymerase that readily accepts the Sp diasteromer 
to synthesize RNA [93]. The function of ribozymes depends on the diasteromer in the phosphate 
backbone, so it remains to be seen how general this approach will be. 
Figure 8. Incorporation of 2'-methylseleno group for derivatizing RNA for crystallization. 
 
3.5.2 GU platforms for direct soaking of divalent metals for RNA for biophysical studies 
Given the current limitations of chemical modifications of RNA for phase determinations, the 
research groups of Batey and Kieft proposed a direct soaking method. GU wobble pair motifs are 
intentionally engineered into seven variants of the SRP RNA to provide heavy atom binding sites with 
high occupancy and low B factors [94]. They demonstrated they could successfully solve the structure 
of three novel RNA sequences that had been refractory to crystallization using other methods [94]. 
How general is this approach? It is likely to be useful on a case-by-case basis. What is clear is that 
there are now a number of different approaches to solving the phase problem in RNA X-ray 
crystallography. These are welcome additions to previous efforts to solving the phase problem as 
discussed earlier.  Int. J. Mol. Sci. 2008, 9                           
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4. Improved methods for ligating large RNAs for biophysical studies 
Solving high-resolution structures of RNA molecules by X-ray crystallography and NMR 
spectroscopy is central to obtaining insights into fundamental biological processes. As discussed 
earlier, major hurdles for NMR structural analyses are crowding and signal decay, and for X-ray 
crystallographic analyses these are preparation of suitable heavy atom derivatives that are essential for 
calculation of crystallographic phases and generation of an electron density map. While improved 
methods for chemical synthesis of RNA exist, generating larger RNAs that are site-specifically 
modified with probes to help overcome some of these obstacles is more difficult. A very promising 
approach is joining RNA pieces together, which can be accomplished in at least four different ways: 
by chemical ligation, by DNA splinted DNA T4 ligation, by T4 RNA ligation, or by deoxyribozyme 
mediated ligation. In this section, the salient features of each method, as well as their advantages and 
limitations are presented. 
4.1 Chemical ligation 
Chemical coupling with cyanogen bromide or a water soluble carbodiimide allows synthesis of both 
3'-5'- and 2'-5'-phosphodiesters. A terminal monophosphate is required, which is donated by either the 
5'- or 3'-substrate, while another substrate supplies the nucleophilic oxygen such as a 3'-OH. The 
segments to be joined are then hybridized to a complementary template. While the yields for coupling 
DNA duplexes can be as high as 96%, the efficiency for RNA oligomers is much lower at 4-16% [95-
96]. Unfortunately, this chemical method is also prone to side reactions of base functional groups with 
the coupling reagents, and the reaction can be exceedingly slow [96]. Accordingly, chemical ligation 
methods are not widely used for synthesis of 3'-5' RNA phosphodiester linkages. Synthesis of RNA 
lariats that have 2'-5' phosphodiester linkages can be slightly more efficient if the water soluble 1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide (EDC) reagent is used [97]. In one case, a 22 nt RNA 
lariat containing a rU branch point was synthesized in 51% yield after a 6 day coupling reaction [97]. 
The chemical method for RNA ligation is therefore currently very limited.  
4.2 DNA splinted T4 DNA ligase based ligation 
One of the most widely used methods for ligating RNA molecules employs T4 DNA ligase [98]. 
DNA ligase in the presence of ATP recognizes a nicked double-stranded substrate by joining one 
oligonucleotide with a 5'-monophosphate (generally referred to as the donor strand) and another 
oligonucleotide with a 3'-OH (called the acceptor molecule) (Figure 9A). The RNA substrates used for 
ligation can be prepared in at least four ways so that the donor substrate begins with a 5'-phosphate and 
the acceptor terminates in a free 3'-OH. For donor RNA that is chemically synthesized, the 5'-
monophosphate can be added during or after the synthesis using T4 polynucleotide kinase and ATP. 
An in vitro transcribed donor RNA can be initiated with GMP or a 5'-XpG-3' dinucleotide, or the 
transcribed RNA can be dephosphorylated and then rephosphorylated. For the in vitro transcribed 
RNAs, abortive initiation products are significant, and therefore they must be purified away from the 
full length donor RNA to prevent competition for the cDNA template. T4 DNA ligase will only ligate 
full (N) length acceptors. But a significant amount of 3'-end heterogeneity caused by N+1 products can Int. J. Mol. Sci. 2008, 9                           
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inhibit ligation efficiency by sequestering donor substrates into unproductive hybrid complexes with 
the cDNA template [98]. The main advantages of this T4 DNA ligase method are: (a) undesired side 
products such as circularization or oligomerization of the donor RNA are minimized because of strict 
requirements for double-stranded complexes; (b) the ligase activity is not dependent on the exact 
sequence at the ligation junction; and (c) most “N+1” T7 RNA polymerase add-ons are effectively 
excluded. A major disadvantage is that T4 DNA ligase is relatively inefficient at joining RNA 
molecules and is required at near stoichiometric amounts in ligation reactions. Larger RNAs are 
needed in milligram quantities for most biophysical studies. But the low yield and the need for large 
amounts of commercially available, but cost-prohibitive, DNA ligase makes it less likely that DNA 
ligase will be widely used for large scale RNA production required for structural biology.  
4.3 DNA splinted T4 RNA based ligation 
An alternative method for RNA ligation, used extensively prior to 1992 [99] but now making a 
resurgence, is to use T4 RNA ligase. This is partly because RNA ligase has some deficiencies that 
have been overcome only recently [100-102]. RNA ligase, like DNA ligase, requires a donor substrate 
with a 5'-phosphate, an acceptor with 3'-OH, and ATP (Figure 9B). But unlike DNA ligase, RNA 
ligase requires single stranded ligation junctions, and therefore using cDNA as a template is difficult. 
To overcome this limitation, Bain and Switzer [103] designed a DNA splint that could not base-pair to 
the elements in the immediate region of the splint junction, such that the donor and acceptor molecules 
were held in close proximity. This created a single-stranded region compatible with T4 RNA ligase 
specificity. Using this approach, they reported a ligation efficiency of 53%. To achieve higher ligation 
efficiencies meant overcoming other known difficulties: ligation efficiency improves only if the last 
two nucleotide sequences of the acceptor terminate in a purine (R4 and R5 in Figure 9B); uridine at 
either the penultimate or 3'-terminal position is particularly inefficient for ligation; for donors, at the 
5'-terminal position, there is a slight preference for pyrimidines (Y1 and Y2 in Figure 9B) over purines 
for improving the ligation efficiency.  
Stark and colleagues did exactly that and the following modifications to improve the ligation 
efficiency to near completion in 30 minutes [101]. First, they protected the donor 3'-OH with a 5'-silyl-
2'-acetoxy-ethyl orthoester (2'-ACE) group (3'-block in Figure 9B) used in oligoribonucleotide 
synthesis. This minimizes the circularization or oligomerization of the donor RNA. Second, they 
chemically incorporated phosphate on the donor strand to minimize the problem of 5'-end 
heterogeneity. Third, they designed an optimized linker at the ligation junction comprising 4-8 single-
stranded nucleotides on the acceptor RNA (X1 X2 X3 R3 R4 in Figure 9B) and 1 or 2 nt on the donor 
RNA (Figure 9B). The splints used in the ligation were designed such that the melting temperature for 
each half of the splint was at least 40˚C and at most 45˚C. Using this strategy they successfully 
synthesized a 128 nt RNA from three synthetic oligonucleotide pieces. 
The question still remains: how well do these DNA splinted ligation schemes work in the context of 
structured RNA elements? Unfortunately very few studies have documented the influence of structure 
on DNA splinted ligation efficiencies using T4 RNA ligase. Preliminary studies from our own group 
suggest that even large (~500 nt), structured RNAs can be ligated to obtain yields of ~33% (Dayie KT 
& Agyeman A, unpublished).  Int. J. Mol. Sci. 2008, 9                           
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Figure 9. 3'-5'-RNA ligation using DNA splints mediated by (A) DNA and (B) RNA ligase. 
 
4.4 Deoxyribozyme based ligation 
Another alternative for the synthesis of native 3'-5'-RNA linkage is to use deoxyribozymes [104-
105]. Silverman’s group identified two artificial deoxyribozymes using in vitro selection experiments. 
Unlike the T4 protein ligases, the two promising ligases require a 2', 3'-diol for the acceptor fragment 
and a 5'-triphosphate functional group for the donor RNA fragment (Figure 10). The two ligases are a 
Mg
2+-dependent 9DB1 and a Zn
2+-dependent 7DES deoxyribozymes [105]. The Mg
2+-dependent 
ligase gives the highest ligation yield at 60-70% with a t1/2 of ~15 minutes, but it functions at the rather 
high pH of 9.0 and elevated Mg
2+ at 37˚C. These reaction conditions may promote nonspecific RNA 
degradation, substantially limiting the usefulness of this ligase for joining large pieces of RNA. 
Incubation at pH 7.5, while possible, lengthens the t1/2 16 fold, again limiting its usefulness. This 
DNAzyme has less restrictive sequence requirements at the ligation site, D
↓RA (where D = A, G, or U; 
and R = A or G). The Zn
2+-dependent ligase is less efficient at ligation than 9DB1 (40-50%). 
Nonetheless it ligates under practical in vitro conditions that reduce the potential for RNA degradation. 
At 23˚C, pH 7.5 and 1 mM Zn
2+, this ligase has a t1/2 of 30 minutes. Together, both ligases provide a 
useful alternative to protein-mediated RNA ligation. In the future, efforts to evolve such DNAzymes to 
work under more physiological conditions to ligate 3'-5'-bonds of any two RNA sequences will be 
extremely valuable.  Int. J. Mol. Sci. 2008, 9                           
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Figure 10. DNAzyme mediated 3'-5'-RNA ligation [105]. 
 
5. Tackling sizeable problems in RNA biophysical chemistry 
In the post-genomic structural biology era, large size matters: most molecular machines are mega 
Dalton machines, making traditional NMR techniques inadequate for the task. For these large systems, 
cryo-electron microscopic reconstructions can provide images of the overall shape but without the 
requisite molecular details. X-ray crystallography is ideally suited for providing these atomic details, 
yet is limited to well structured and conformationally homogeneous systems. NMR spectroscopy is 
ideally positioned to tackle such systems. As discussed above, the problems of overlap and size that 
plague traditional approaches can be effectively circumvented using these emerging technologies. In 
particular, modular multi-component biological systems are particularly suited for a divide-and-
conquer approach that can take advantage of these technologies. By divide-and-conquer we mean 
working on multi-component systems that can be broken down into folded “domains” and then 
probing the labeled components singly or in various combinations with unlabeled components. In this 
last section, two biological problems that are amenable to this approach are described. 
5.1 Structural basis for encapsidation of the genome of the Moloney Murine Leukemia Virus 
Retroviruses are a family of RNA viruses that cause a number of diseases such as AIDS, 
neurological disorders, tumors, and leukemias [106]. The structural basis for how retroviruses select 
and package their genomes will be helpful for designing new antiviral therapies. The Moloney Murine 
Leukemia Virus (MMLV) is widely used in human gene therapy trials and as a model system to study 
retroviral assembly and genome encapsidation. It contains a 350-nt fragment called the Ψ-site that 
directs packaging and dimerization of the viral RNA. Remarkably, a sub-fragment of the Ψ-site 
containing ~100 nt can direct RNA packaging into virus-like particles, albeit at reduced efficiency. To 
gain insight into the molecular basis of genome packaging in MMLV, D’Souza and Summers 
determined, using NMR, the 3D structure of the 101 nt RNA sub-fragment of the Ψ-site in complex 
with a nucleocapsid domain of the Gag polyproteins important for mediating this interaction [107]. To 
tackle the largest known NMR RNA structure, the authors had to use a nucleotide-specific isotopic 
labeling strategy to overcome the extensive chemical shift overlap [61]. These methods are analogous 
to those described in making labeled NTPs in sections 3.0-3.4 above. With this approach, they were Int. J. Mol. Sci. 2008, 9                           
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able to distinguish internucleotide from intranucleotide nuclear Overhauser effects (NOE), and obtain 
valuable distance information to compute a moderate resolution structure [61, 107]. The disadvantage 
of this approach is that it required preparing eight different isotopically labeled samples and collecting 
several 2D, 3D, and 4D NMR datasets, making it both labor and instrumentation-intensive [61]. Uses 
of some of the technologies discussed above are likely to help with getting higher resolution structures 
of this biologically important complex.  
 
5.2 Towards the structural basis for Group II Intron ribozyme catalytic funtion 
A large riboncucleoprotein complex called the spliceosome [4] mediates the accurate removal of 
intervening RNA sequences (introns) from eukaryotic pre-mRNAs [4, 108]. At the heart of this critical 
biological process lies a simple chemical reaction, which is carried out by nucleophilic attack on the 
5'-splice site phosphate by the 2'-hydroxyl of an intronic branch point adenosine to generate a free 5'-
exon and an intron-3'-exon. In the following step, the freed 3'-hydroxyl of the 5'-exon attacks the 3'-
splice site to release the intron and ligate the 3'-exon to the 5'-exon. Remarkably, a class of RNAs 
called group II introns (G2I) performs the same chemical reactions as the spliceosome, yet only uses 
RNA. Because the group II introns share several structural features and identical reaction mechanism 
with the messenger RNA splicing machinery, they are an important model system for exploring the 
mechanisms for RNA catalysis. The key question is: what is the molecular basis of catalysis? 
Determining the 3D architecture of the group II intron is the beginning process to answer this question, 
and in turn this requires defining an experimentally well-behaved model system. We recently 
reconstructed a group II intron from Pylaiella littoralis into a highly active form by combining an 
unstructured 22 nt substrate, a 36 nt domain 5 (D5) hairpin, and a 493 nt domains 1 through 3 (D123) 
[109-112]. This new tripartite ribozyme system functions under low salt conditions attractive for NMR 
structural studies and has enabled us to determine a very high resolution NMR structure of the 
catalytic lynchpin, D5 [110]. We have also quantitatively assayed the binding of each component using 
a fluorescence native gel mobility shift assay we developed in conjunction with fluorescent anisotropy 
measurements [109, 112]. Parenthetically, this fluorescent method takes advantage of a multicolor 
fluorescent-based gel assay to directly monitor RNA-RNA interactions, without the need to use 
hazardous 
32P labeled probes [109, 112-113]. Using pre-steady state-kinetic experiments, we have 
shown that the cleavage reaction is pH-dependent, suggesting that the chemical step is rate limiting 
[109].  
Using a divide-and-conquer approach, we have shown that NMR experiments can provide a 
detailed view of the binding interface between the catalytically important D5 and the large 100 kDa 
D123 fragment. The regions of D5 that undergo the greatest chemical shift changes correspond to 
those areas predicted by footprinting experiments [109]. Using NMR relaxation measurements, and 
newly developed software for RNA dynamic analysis, we have shown that regions of D5 important for 
catalysis and binding are flexible, suggesting that motion is an important component of catalysis that 
requires further exploration [111].  
  In conclusion, using very simple NMR experiments on multidomain structures, wherein one 
component is preferentially labeled with NMR-active nuclei, one can probe in atomic detail the Int. J. Mol. Sci. 2008, 9                           
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binding interface of numerous molecular machines [61, 109, 114]. In the case of group II introns, this 
approach enabled us to identify a key aspect of catalysis: the highly conserved catalytic lynchpin, D5, 
must undergo large conformational changes to adapt to the rest of the intronic elements to carry out 
catalysis [109-111]. We anticipate that similar approaches applied to other large macromolecular RNA 
complexes will provide fundamental insight into biological functions that may not be readily 
accessible from static X-ray structures. 
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Note Added in Proof 
A new structure of the group II intron was published and as predicted from simple NMR 
experiments, D5 undergoes a very large conformational change within the intronic context [115,116]. 
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